Fingerprint
Dive into the research topics of 'Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphoma
Huda Salman, Alejandra Perez, Joseph A. Sparano, Howard Ratech, Abdissa Negassa, Una Hopkins, Gina Villani, Joachim Fuks, Peter H. Wiernik
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations